Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b4ee13af463c18c765406625e1c5d44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1dab6fc34655118d79138d29f8704ce0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76696a45a8fdc2fa9a4f6c1850edc8f9 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-523 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0258 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-108 |
filingDate |
2010-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3db51ff0c2e44f37e238d01e76c7f662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6114566c359a81718443f7aff139b3de |
publicationDate |
2016-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9327019-B2 |
titleOfInvention |
Attenuated enterohemorrhagic E. coli-based vaccine vector and methods relating thereto |
abstract |
An attenuated enterohemorrhagic E. coli -based vaccine vector is disclosed. Enterotoxigenic E. coli colonization factor antigen 1 and the B subunit of E. coli heat labile toxin have been expressed in the attenuated enterohemorrhagic E. coli vector strain. Immunized animals are further protected against lethal and non lethal challenges with the enterotoxigenic E. coli strain. Immunization of mice with the vaccine construct induces mucosal antibody against both antigens, establishing the attenuated E. coli vector strain as a generally useful vector for presenting one or more antigens to a subject in a vaccine. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10286054-B2 |
priorityDate |
2009-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |